A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel

Summary

Phase 1/2 study enrolling up to 60 healthy volunteers in Phase 1 followed by approximately 150 subjects with acne vulgaris in Phase 2.

Timeline

Start

2015-09-17

Primary completion

2017-02-16

Completion

2017-03-17

Drugs

Indications